Respiratory Pathogen Panel (“RPP”) test pinpoints the influenza virus, along with a number of other respiratory viruses and pneumonia causing bacteria, so that providers can render treatment swiftly and accurately; possibly reducing the severity and duration of infection. Treatment protocols for bacterial pathogens and viral pathogens are vastly different – identifying the pathogen is key to proper and effective treatment.
As part of a management service agreement Med Services medical practices a CLIA waived respiratory program that provides accurate RPP results within 1 hour. The technology offers the only in-office PCR test approved by the FDA, CLIA and Medicare in the nation. The Med Services and MDCommerce team implement and assist in the management of an in-network flu and respiratory testing site, with no initial out-of-pocket expenses for participating practices.
“We are pleased to join the Med Services delivery system to enable practices to deliver faster care for patients and achieve a net increase in their revenue.” Said Gordon Bell, President of MDCommerce Inc..